89bio Inc (ETNB) — Financial Flexibility Index
89bio Inc (ETNB) has a Financial Flexibility Index of -1.23x as of June 2025. Free cash flow of $-100.42 Million (operating CF $-100.42 Million minus capex $0.00) represents -1% of total liabilities ($81.75 Million). Check ETNB strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
89bio Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for 89bio Inc across 7 annual periods. See ETNB current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for 89bio Inc (2018–2024)
Year-by-year free cash flow to debt coverage for 89bio Inc. For the full company profile including market capitalisation, see market cap of 89bio Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.72x | $-367.81 Million | $-367.82 Million | $77.90 Million | ▼ -119.2% |
| 2023 | -2.15x | $-129.18 Million | $-129.19 Million | $59.96 Million | ▼ -19.5% |
| 2022 | -1.80x | $-81.08 Million | $-81.09 Million | $44.99 Million | ▲ +14.3% |
| 2021 | -2.10x | $-76.72 Million | $-76.78 Million | $36.47 Million | ▲ +63.0% |
| 2020 | -5.68x | $-46.12 Million | $-46.24 Million | $8.11 Million | ▼ -25.9% |
| 2019 | -4.51x | $-25.32 Million | $-25.46 Million | $5.61 Million | ▼ -896.1% |
| 2018 | -0.45x | $-12.43 Million | $-12.47 Million | $27.43 Million | — |